Pharmaceutical Articles

RSS | Login | Register

Wyeth, Elan halt study of Alzheimer's vaccine

Stephen McGuire April 18, 2008

Wyeth and Elan have suspended a clinical study of their jointly developed Alzheimer's vaccine ACC-001 after a patient receiving the treatment was hospitalized for nearly two weeks with skin ulcers.

Crestor to benefit as ENHANCE smoke clears: survey

Stephen McGuire April 10, 2008

Expect AstraZeneca's Crestor to emerge as the big winner in the aftermath of Merck/Schering Plough's Vytorin debacle, primary care physicians (PCPs) said.

Takeda to buy Millennium for $8.8 billion

Stephen McGuire April 10, 2008

Takeda Pharmaceutical of Japan has announced plans to purchase US biotech firm Millennium Pharmaceuticals in a deal valued at nearly $9 billion.

GlaxoSmithKline to close Reliant HQ, lay off marketers

Stephen McGuire April 04, 2008

GlaxoSmithKline will close the Liberty Corner, NJ, headquarters of Reliant Pharmaceuticals and plans to lay off 109 workers at the site, The Star-Ledger of New Jersey reports.

Prevacid patent upheld

Stephen McGuire April 02, 2008

A federal judge has upheld a Takeda Pharmaceutical and Abbott Laboratories patent for the drugmakers' jointly marketed heartburn drug Prevacid.

Docs rate Merck tops for ePromotion

Stephen McGuire March 31, 2008

Doctors rate Merck's ePromotion efforts as tops in the industry, according to pharmaceutical marketing data firm Verispan.

Company news

March 27, 2008

Pfizer has received antitrust approval in its bid to purchase Encysive Pharmaceuticals for about $195 million.

Are FDA deadlines behind marketplace safety issues?

Stephen McGuire March 27, 2008

FDA deadlines for new drug approvals may lead to safety issues with medicines once they make it to market, a New England Journal of Medicine study indicates.

FDA looking at possible Singulair suicidality connection

Matthew Arnold March 27, 2008

The FDA issued an early communication advising that it is investigating a possible risk of suicidality with Merck's allergy and asthma drug Singulair.

Sanofi-Aventis and Lilly in Cialis marketing pact

Ben Comer March 27, 2008

Sanofi-Aventis has teamed with Eli Lilly in a collaboration to market erectile-dysfunction drug Cialis (tadalafil) to US urologists.

« Previous

Most Emailed

Most Recent

RSS